在患者中,分娩类型,母乳养开始和产后住院时间的差异
Kelly Rios-Papachristos1,2, Sarah Lindsay2,3, Ya-Huei Li4
1Department of Obstetrics and Gynecology, University of Connecticut, Farmington, Connecticut, USA.
Epilepsia
|July 28, 2025
概括
与没有的患者相比,患有 (PWE) 的患者经历了更糟糕的孕产妇结果,包括较高的剖腹产和延长的产后住院率. 是出生后长时间住院的危险因素.
科学领域:
- 产科和妇科 产科和妇科
- 神经学 神经学
- 公共卫生 公共卫生
背景情况:
- 影响每年0.3%-0.5%的出生.
- 患有患者 (PWE) 的产科医疗利用率增加,母乳养率降低.
- 在PWE中剖腹产率受到争议,需要进一步调查.
研究的目的:
- 调查和PWE中母亲的结果之间的关联.
- 为了比较PWE和没有的患者 (PWoE) 之间的剖腹产率,母乳养开始和产后住院时间.
- 分析抗发作药物 (ASM) 对PWE中母亲结局的影响.
主要方法:
- 在2018年9月1日至2023年5月31日期间,对33,764次交付进行了回顾性研究.
- 倾向分数匹配 (PSM) 用于比较PWE和PWoE在各种孕产妇和新生儿结局上.
- 多变量后勤回归确定了长时间的产后住院预测因素.
主要成果:
- 与PWoE相比,PWE的剖腹产率 (36.1%对28.2%),早产率 (15.0%对8.4%) 和新生儿重症监护室入院率 (9.9%对5.4%) 显着更高.
- 独立地与延长产后住院的更高风险相关 (OR=1.8,95% CI=1.0-3.1).
- 只有54.8%的PWE在分娩住院期间使用ASM,比预期的更低.
结论:
- 与PWoE相比,PWE经历了较差的孕产妇结果.
- 是延长产后住院治疗的重要危险因素.
- 在PWE中,在分娩时使用抗发作药物的比例低于预期,因此需要进一步研究.
相关概念视频
Epilepsy and Seizures: Overview
281
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
281
Seizures: Classification
596
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
596
Local Anesthetics: Clinical Application as Epidural Anesthesia
499
Epidural anesthetics are administered in the fat-filled epidural space, the outermost part of the spinal canal. This technique is commonly employed for pain management and anesthesia during lower abdomen and pelvis surgeries or labor and delivery.
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
Since epidural anesthetics can be infused through an epidural catheter, all types of drugs, including short-acting ones, can be administered. Chloroprocaine and lidocaine are examples of short and long-duration anesthetics, respectively. Bupivacaine...
499
Antiepileptic Drugs: Potassium Channel Activators
278
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
278
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
451
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
451


